Home Page Contact Us Site Map
Home    Articles      Facts      Charity      Lawyers      Directory      Add a Link  &nbs
 
Alimta with cisplatin
The Food and Drug Administration (FDA) approved Alimta (pemetrexed disodium) for ...more
World Trade Center Asbestos
EPA collected wipe samples in a subset of the households that were...more
Diseases Caused By Asbestos Exposure
Pleural plaque is not cancer, and it does not cause cancer...more
Mesothelioma: A Killer Lurks in the Lungs

Back to Health News Page

Home Page

 

 

Combat Research: 1 in 5 Suffer Head and Neck Wounds

 

September 24, 2004 06:03:17 AM PDT , HealthDay

 

By E.J. Mundell
HealthDay Reporter

 

FRIDAY, Sept. 24 (HealthDayNews) -- A significant percentage of U.S. soldiers wounded in Iraq and Afghanistan are suffering potentially lethal wounds to the head and neck, areas not covered by today's improved body armor.

A unique report on combat injuries found that, in a 14-month period, one of every five soldiers injured in battle and airlifted to an American military hospital in Germany suffered from this type of injury.

The finding, presented this week by a U.S. military surgeon at a conference in New York City, led the research team to urge that more head-and-neck specialists be deployed closer to the front, advice that the U.S. Air Force has just begun following.

"I think that any time you can bring the surgeons that definitively treat those types of injuries closer to the patient, seeing them in a more timely manner, it's always better for the patient," said study co-author Lt. Col. Michael S. Xydakis, an ear-nose-and-throat specialist and head-and-neck surgeon with the U.S. Air Force medical corps.

Xydakis, 40, spent the first year of the Iraqi conflict working with incoming wounded at the U.S. military's Landstuhl Regional Medical Center, part of Ramstein Air Force Base in southwestern Germany. Landstuhl is the facility receiving the majority of casualties from combat in Iraq and Afghanistan.

Working with two information specialists and Dr. John Casler, chief of head and neck surgery at Walter Reed Army Medical Center in Washington, Xydakis used a computerized patient tracking system to categorize the nature of injuries to more than 11,000 wounded soldiers who were admitted to Landstuhl between Jan. 1, 2003, and March 19, 2004.

"This operation we have ongoing right now in Iraq is the first sustained use of ground combat since Vietnam," Xydakis said. Keeping in mind changes in armor and tactics, his team sought to determine patterns of injury in troops today, and whether medical personnel were being properly deployed to respond to the types and numbers of casualties.

"What the military really cares about is 'Is the stuff that we're providing our troops really effective?" he explained.

Xydakis' team of researchers report that 16 percent of all the 11,287 soldiers airlifted from Iraq or Afghanistan and cared for at Landstuhl in that 14-month period were treated for injuries to the face, neck and throat below the helmet line. But when the researchers focused on troops classified as having suffered "battle injuries," the number of patients with at least one type of head and neck trauma rose to 21 percent.

The study ended in March, but Xydakis suspects injury patterns may have changed somewhat since then, due to the evolving nature of the Iraqi resistance. "My sense is that you're going to see more blast injuries and less penetrating injuries," he said.

He presented the findings Sept. 20 at the annual meeting of the American Academy of Otolaryngology -- Head and Neck Surgery.

Before the advent of a super-tough synthetic fiber called Kevlar, most combat deaths and injuries stemmed from wounds to the chest or skull, Xydakis said. However, lightweight Kevlar resists penetration by nearly all high-velocity bullets and shrapnel. It is now the main component of all chest, back armor and helmets worn by American troops today.

Xydakis said he's not sure if enemy combatants are aiming for these areas in the knowledge that the chest and upper head are nearly invulnerable due to armor. However, he said, "you have a lot of emerging tactics now, because they know that it is very hard to put down an American soldier because of what they are wearing." Furthermore, "if a soldier is crouched down in the shooting position, that's the only exposed area."

Whatever the enemy's intent, even nonfatal injuries in this vulnerable area can have devastating results, including shattered jaws, impaired breathing, brain damage and blindness, Xydakis noted.

He said head and neck injuries occurring on the battlefield are generally more severe than those he encountered in civilian patients during his residency in Minnesota. "The weapons are so much more powerful, blast injuries aren't common in the civilian world -- it's clearly different," he said. "There's a spectrum -- you've got massive, mutilating injuries."

The relative youth of patients and the extent of their injuries can be tough to deal with, even for a military surgeon with a long experience of caring for wounded. "It tugs on the heartstrings," Xydakis said. "It works at many levels."

Right now, he explained, most American troops injured in the face and neck first receive Level 1 care, consisting of first aid and other stopgap measures provided by a combat medic in their fighting unit. They are then quickly transported to what's known as Level 2 or 3 care -- either a small, mobile medical staff following the unit, or a larger field hospital.

If more care is needed, the patient is airlifted to Landstuhl, the military's only Level 4 center outside the United States. These patients are sometimes accompanied by a surgeon, nurse and anesthesiologist in a journey that takes an average of 18 hours.

Given the increased incidence of head and neck injuries, Xydakis and his colleagues are urging all branches of the U.S. military to move specialized surgeons closer to the front.

The Air Force is already heeding his advice, Xydakis added: "There will be a rotation all the time now for one [Air Force ENT/head and neck surgeon] into the theater. I think they are picking up on this, now that we've got the data coming out."

The first Air Force ENT/head-and-neck surgeon is already working in Iraq, Xydakis added, "but it's my idea that we need to get all of the services to do the same."

Xydakis noted that he was speaking purely as a surgeon and researcher. "All I can do is present the data," he said.

Lt. Col. Guillermo Tellez, chief of the ENT/head and neck department at Landstuhl Medical Center, said Xydakis' work is part of an ongoing "feedback mechanism" between surgeons at the medical center and health-care teams closer to the front.

Landstuhl surgeons "are able, on a continuous basis, to reach the troops and trauma teams [in Iraq] to improve care, based on what we are seeing here with our casualties," Tellez said. "It brings light to all of the processes. What our goal is here is to continue to provide state-of-the-art care across all specialties."

Xydakis added that moving surgeons into the combat theater would also cut back on airlifts to Germany. That would serve the interests of many troops, he said, because a majority of young soldiers wish to return to their units as soon as they recover.

"Especially in the Special Operations troops, and the Army and Marine units, the esprit de corps is such that they don't want to leave their battle buddies," he said. "It's really noble. They don't want to leave their units."

More information

Learn about what the U.S. Defense Department is doing for soldiers at the Pentagon.

 

New EU panel to study safety of herbal medicines

Last Updated: 2004-09-23 14:03:05 -0400 (Reuters Health)

LONDON (Reuters) - The safety of herbal medicines, which are widely used on the basis of scant scientific evidence, will be investigated by a new panel of European experts.

The Committee on Herbal Medicinal Products held its inaugural meeting in London on Thursday and will meet every two months under new EU legislation designed to protect consumers.

Not everything natural is risk free, and the use of herbal remedies is a growing concern worldwide.

The World Health Organisation warned in June that adverse drug reactions to herbal and other alternative medicines had more than doubled in three years and urged governments to tighten controls.

Thomas Lonngren, executive director of the London-based European Medicines Agency, said the watchdog's new panel would harmonise regulation of the industry across the European Union.

Until now, rules have varied from country to country, with some states including Germany, the biggest user, having tight controls, but oversight in some markets proving lax.

More than 4,500 herbal medicines and preparations are sold across the EU, although 300-400 make up 90 percent of sales.

Konstantin Keller, chairman of the new herbal medicines committee, said the range of products available and their widespread use make effective scrutiny of side effects imperative, even though serious problems are rare.

"The main problem relates to chronic toxicity, such as carcinogenicity, because it may take 10 years to make a connection between cancer and use of a herbal medicine," he told reporters.

Concerns about the safety of natural treatments was highlighted recently when weight-loss product ephedra was pulled from the market following evidence that it could increase risks of heart attacks, strokes and deaths.

Another worry is that herbal medicines sold over-the-counter may interact dangerously with prescription drugs. Keller said this problem was exacerbated because many people taking alternative medicines did not tell their doctors.

Ginkgo, for example, may intensify the effects of the blood-thinning drug warfarin, raising the risk of serious bleeding, while St. John's Wort speeds up the rate at which drugs are metabolised, lessening their effect.

Because of the long history of herbal medicine, the new EU system will not require full clinical trials to prove safety. But manufacturers will have to prove that products have been in medical use for at least 30 years, including 15 years in the EU.

That could exclude some herbal medicines introduced recently into Europe from China or elsewhere in Asia, as well as South America or Africa.

Copyright © 2004 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

 

Back to Original Article : News You Can Use

 

Continue with:

THURSDAY, Sep. 23 (HealthDayNews) -- While it may seem strange, what happened to you in the womb may affect your suicide risk later in life. That's the conclusion of a study in the Sept. 25 issue of The Lancet that found if you were born to a teenage mother or had a low birth weight, the odds are higher that you might commit suicide as a teenager or young adult.

THURSDAY, Sept. 23 (HealthDayNews) -- About half the patients with aggressive non-Hodgkin's lymphoma in the United States don't receive the recommended dose and schedule of chemotherapy, which reduces their chances for remission or cure, says a University of Rochester Medical Center study. Researchers reviewed data for 4,552 patients in 567 cancer practices across the United States and found that between 48 percent to 53 percent of patients with non-Hodgkin's lymphoma (NHL) were given less than 85 percent of the recommended chemotherapy dose intensity.

THURSDAY, Sept. 23 (HealthDayNews) -- Excessive drinking took more than 75,000 lives in the United States in 2001, shortening the lives of each of those who died by an average of more than 30 years, a new government report says. In all, a total of 2.3 million "years of potential life" were lost to alcohol abuse, according to the report from the U.S. Centers for Disease Control and Prevention.

FRIDAY, Sept. 24 (HealthDayNews) -- The use of gene therapy to deliver nerve growth factor into areas of the brain where neurons are degenerating, to reverse the ravages of Alzheimer's disease, is being investigated by Rush University Medical Center scientists. If this technique proves successful, it could be a major step forward in finding a way to slow the course of Alzheimer's disease.

Repligen Corp., a biotechnology company that concentrates on pediatric diseases, said Friday that it launched an early-stage clinical trial of a treatment for patients with obsessive-compulsive disorder. Shares of Repligen were up 14 cents, or 7.25 percent, at $2.07 in afternoon trading on the Nasdaq. The Phase I trial of RG1068, a synthetic form of the human hormone secretin, will primarily test the safety and tolerability of two dose levels in up to 16 patients.

 

Anxiety Overview Provided by A.D.A.M., Inc. Definition Anxiety is a feeling of apprehension or fear that lingers. The source for this uneasiness is not always known or recognized which adds to the distress: "Everything stresses me out." "I am always worried." Alternative Names Feeling uptight; Stress; Tension; Jitteriness; Apprehension

 

 

 


General Information About Malignant Mesothelioma
Where can I find Asbestos?
Diagnosing Mesothelioma
Asbestos Information
Damages and Settlements
Medical Procedures
Drugs and Medications
Mesothelioma News
Articles       Facts       Charity       Lawyers       Directory       Add a Link       Clinical Trials       State Coverage